Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Safety of Intranasal Fentanyl (PecFent) in the Treatment of Procedural Pain in the Elderly With or Without Background Treatment.

Trial Profile

Safety of Intranasal Fentanyl (PecFent) in the Treatment of Procedural Pain in the Elderly With or Without Background Treatment.

Status: Completed
Phase of Trial: Phase II/III

Latest Information Update: 06 Apr 2022

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Fentanyl (Primary)
  • Indications Procedural pain
  • Focus Adverse reactions
  • Acronyms FENTA

Most Recent Events

  • 02 May 2018 Status changed from recruiting to completed.
  • 25 Oct 2017 Planned End Date changed from 1 Sep 2017 to 1 Dec 2017.
  • 25 Oct 2017 Planned primary completion date changed from 1 Sep 2017 to 1 Dec 2017.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top